The molecular defect in a COOH-terminal-modified and shortened mutant of human serum albumin
L Minchiotti1, M Galliano, P Iadarola
1Department of Biochemistry, University of Pavia, Italy.
Abstract:
Albumin Venezia is a fast migrating genetic variant of human serum albumin which, in heterozygous subjects, represents about 30% of the circulating protein. The molecular defect in this variant was studied in a subject possessing an atypical level of the mutant (80% of the total protein) and in other members of his family. Albumins, isolated from the sera of the propositus and his heterozygous relatives, were treated with CNBr and the resulting fragments analyzed by isoelectric focusing. The peptides were then isolated in a homogeneous form by reverse-phase high performance liquid chromatography and submitted to sequence analysis. The results show that albumin Venezia possesses a shortened polypeptide chain, 578 residues instead of 585, completely variant from residue 572 to the COOH-terminal end: sequence: (see text). This extensive modification may be accounted for by the deletion of exon 14 and translation to the first terminator codon of exon 15, which normally does not code for protein. The absence of a basic COOH-terminal dipeptide in the mature molecule can be explained by the probable action of serum carboxypeptidase N. Additional support for such action comes from examination of the remaining 20% of the total albumin of the propositus, which is found to contain an extra Arg at its COOH terminus, probably due to partial digestion by carboxypeptidase N. The low serum level of the variant in heterozygous subjects suggests that the COOH-terminal end of the molecule is critical for albumin stability.
Insights
Albumin Venezia, a human serum albumin variant, has a shortened chain due to exon 14 deletion. This genetic defect impacts albumin stability, affecting protein levels in circulation.
Area of Science:
- Biochemistry
- Human Genetics
- Molecular Biology
Background:
- Albumin Venezia is a fast migrating genetic variant of human serum albumin.
- In heterozygous individuals, it constitutes approximately 30% of circulating protein.
Purpose of the Study:
- To investigate the molecular defect of albumin Venezia.
- To analyze the variant in a subject with an atypical level (80%) and family members.
Main Methods:
- Serum albumins were isolated and treated with cyanogen bromide (CNBr).
- Resulting fragments were analyzed by isoelectric focusing.
- Peptides were purified using reverse-phase high-performance liquid chromatography and sequenced.
Main Results:
- Albumin Venezia has a shortened polypeptide chain (578 instead of 585 residues).
- Extensive modification from residue 572 to the COOH-terminal end suggests exon 14 deletion and translation into exon 15.
- Absence of a basic COOH-terminal dipeptide is likely due to carboxypeptidase N action.
Conclusions:
- The genetic defect in albumin Venezia involves a shortened polypeptide chain and altered COOH-terminus.
- Carboxypeptidase N action may contribute to the observed molecular modifications.
- The low serum level of the variant suggests the COOH-terminal end is critical for albumin stability.
More Related Videos
09:37A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
Related Concept Videos
Mutations
Cooperative Allosteric Transitions
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Proteoglycans
Protein Denaturation
Inborn Errors of Metabolism
